Literature DB >> 18694713

Nasal and sinus disease in cystic fibrosis.

John M Robertson1, Ellen M Friedman, Bruce K Rubin.   

Abstract

Paranasal and sinus disease is present in almost every patient with cystic fibrosis. However, symptoms are rarely reported. Some aspects including polyposis and microbial flora change with patient age. Endoscopy and computerised tomography have broadened our understanding of how this disease affects the sinuses, including an increased recognition of polyposis than previously thought and identification of several disease specific entities such as abnormalities of the lateral nasal wall and uncinate process. Few randomised, controlled trials evaluating medical or surgical treatments of CF sinus disease exist. Sinus surgery may provide some benefit, though there are no established selection criteria for appropriate candidates. A link between sinus disease and lower respiratory tract function may contribute to general health and survival following lung transplantation. Complications of sinonasal disease in CF are rare and include mucoceles and periorbital abscesses.

Entities:  

Mesh:

Year:  2008        PMID: 18694713     DOI: 10.1016/j.prrv.2008.04.003

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  22 in total

1.  Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.

Authors:  Dale Farkas; Michael Hindle; Serena Bonasera; Karl Bass; Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-08-29       Impact factor: 2.849

Review 2.  Cystic fibrosis chronic rhinosinusitis: a comprehensive review.

Authors:  Mohamad R Chaaban; Alexandra Kejner; Steven M Rowe; Bradford A Woodworth
Journal:  Am J Rhinol Allergy       Date:  2013 Sep-Oct       Impact factor: 2.467

Review 3.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

4.  16S rRNA gene sequencing reveals site-specific signatures of the upper and lower airways of cystic fibrosis patients.

Authors:  Sarah K Lucas; Robert Yang; Jordan M Dunitz; Holly C Boyer; Ryan C Hunter
Journal:  J Cyst Fibros       Date:  2017-08-18       Impact factor: 5.482

Review 5.  Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

Authors:  Anders Folkesson; Lars Jelsbak; Lei Yang; Helle Krogh Johansen; Oana Ciofu; Niels Høiby; Søren Molin
Journal:  Nat Rev Microbiol       Date:  2012-11-13       Impact factor: 60.633

6.  Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection.

Authors:  Susse Kirkelund Hansen; Martin Holm Rau; Helle Krogh Johansen; Oana Ciofu; Lars Jelsbak; Lei Yang; Anders Folkesson; Hanne Østergaard Jarmer; Kasper Aanæs; Christian von Buchwald; Niels Høiby; Søren Molin
Journal:  ISME J       Date:  2011-06-30       Impact factor: 10.302

Review 7.  Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis.

Authors:  Helen Beer; Kevin W Southern; Andrew C Swift
Journal:  Cochrane Database Syst Rev       Date:  2015-06-22

Review 8.  Sinus bacteriology in patients with cystic fibrosis or primary ciliary dyskinesia: A systematic review.

Authors:  Maria E Møller; Mikkel C Alanin; Christian Grønhøj; Kasper Aanæs; Niels Høiby; Christian von Buchwald
Journal:  Am J Rhinol Allergy       Date:  2017-09-01       Impact factor: 2.467

9.  Lentiviral-mediated phenotypic correction of cystic fibrosis pigs.

Authors:  Ashley L Cooney; Mahmoud H Abou Alaiwa; Viral S Shah; Drake C Bouzek; Mallory R Stroik; Linda S Powers; Nick D Gansemer; David K Meyerholz; Michael J Welsh; David A Stoltz; Patrick L Sinn; Paul B McCray
Journal:  JCI Insight       Date:  2016-09-08

10.  T2R38 genotype is correlated with sinonasal quality of life in homozygous ΔF508 cystic fibrosis patients.

Authors:  Nithin D Adappa; Alan D Workman; Denis Hadjiliadis; Daniel J Dorgan; Danielle Frame; Steven Brooks; Laurel Doghramji; James N Palmer; Corrine Mansfield; Danielle R Reed; Noam A Cohen
Journal:  Int Forum Allergy Rhinol       Date:  2015-12-17       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.